dc.contributor.author | Al Qaraghuli, Mohammed M | |
dc.contributor.author | Palliyil, Soumya | |
dc.contributor.author | Broadbent, Gillian | |
dc.contributor.author | Cullen, David C | |
dc.contributor.author | Charlton, Keith A | |
dc.contributor.author | Porter, Andrew J | |
dc.date.accessioned | 2015-11-04T16:17:02Z | |
dc.date.available | 2015-11-04T16:17:02Z | |
dc.date.issued | 2015-10-24 | |
dc.identifier.citation | Al Qaraghuli , M M , Palliyil , S , Broadbent , G , Cullen , D C , Charlton , K A & Porter , A J 2015 , ' Defining the complementarities between antibodies and haptens to refine our understanding and aid the prediction of a successful binding interaction ' , BMC Biotechnology , vol. 15 , 99 . https://doi.org/10.1186/s12896-015-0217-x | en |
dc.identifier.issn | 1472-6750 | |
dc.identifier.other | PURE: 58434959 | |
dc.identifier.other | PURE UUID: 44eafc7e-7967-4525-b492-73a32b7f9b0a | |
dc.identifier.other | PubMed: 26498921 | |
dc.identifier.other | Scopus: 84945126979 | |
dc.identifier.uri | http://hdl.handle.net/2164/5155 | |
dc.description | Acknowledgments The authors would like to thank the Scottish Universities Life Sciences Alliance (SULSA) for their support. | en |
dc.format.extent | 14 | |
dc.language.iso | eng | |
dc.relation.ispartof | BMC Biotechnology | en |
dc.rights | © 2015 Al Qaraghuli et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | en |
dc.subject | hapten | en |
dc.subject | phage display | en |
dc.subject | antibody modeling | en |
dc.subject | hapten docking | en |
dc.subject | canonical structure | en |
dc.subject | CDR length | en |
dc.subject | electrostatic potential | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Defining the complementarities between antibodies and haptens to refine our understanding and aid the prediction of a successful binding interaction | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Biological Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1186/s12896-015-0217-x | |
dc.identifier.vol | 15 | en |